|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Lanabecestat>> Market Analysis Reports |
Market Analysis Reports of Lanabecestat |
|
Alzheimer's Disease [2017] ... ; Merck & Co.) Elenbecestat (E-2609; Eisai/Biogen) Lanabecestat (AZD3293; AstraZeneca/Eli Lilly) JNJ ... Alzheimer's: Disease Inights and Market Forecasts to 2024 Delivery time for this report is 5 days “Alzheimer’s: Disease Insights and Market Forecasts to 2024” report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Alzheimer’s disease in the US, EU5 (Germany, France, ... Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H1 2018 Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H1 2018 SUMMARY Beta Secretase 1 (Aspartyl Protease 2 or ... Alzheimer's: Pipeline Assessment and Insights Delivery time for this report is 2-3 days “Alzheimer’s: Pipeline Assessment and Insights” report delivers an in-depth understanding of the disease, highlights all the pipeline products in different phases of development for the disease including the ... |